Carbohydrate Deficient Glycoprotein Syndrome Type Ig

Last updated: February 8, 2026Reviewed date: February 8, 2026Reading time: 19 min read
Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Patient Mode

Understand this article easily

Switch between simple English and easy Bangla patient notes. This is for education and does not replace a doctor consultation.

ALG12-CDG (CDG-Ig) is a rare, inherited disease that affects how the body adds sugar chains to proteins. This sugar-adding process is called glycosylation. In ALG12-CDG, a gene named ALG12 does not work correctly. The ALG12 protein’s normal job is to put the eighth mannose sugar...

For severe symptoms, danger signs, pregnancy, child illness, or sudden worsening, seek urgent medical care.

বাংলা রোগী নোট এখনো যোগ করা হয়নি। পোস্ট এডিটরে “RX Bangla Patient Mode” বক্স থেকে সহজ বাংলা সারাংশ যোগ করুন।

এই তথ্য শিক্ষা ও সচেতনতার জন্য। এটি ডাক্তারি পরীক্ষা, রোগ নির্ণয় বা প্রেসক্রিপশনের বিকল্প নয়।

Article Summary

ALG12-CDG (CDG-Ig) is a rare, inherited disease that affects how the body adds sugar chains to proteins. This sugar-adding process is called glycosylation. In ALG12-CDG, a gene named ALG12 does not work correctly. The ALG12 protein’s normal job is to put the eighth mannose sugar onto a growing sugar chain inside the cell. When ALG12 does not work, many proteins are made with incomplete sugars,...

Key Takeaways

  • This article explains Types in simple medical language.
  • This article explains Causes in simple medical language.
  • This article explains Common symptoms and signs in simple medical language.
  • This article explains Diagnostic tests in simple medical language.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Fever with very low white blood cells or known immune suppression.
  • Unusual bruising, persistent bleeding, black stools, or severe weakness.
  • Shortness of breath, fainting, confusion, or rapidly worsening fatigue.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.
Definition

ALG12-CDG (CDG-Ig) is a rare, inherited disease that affects how the body adds sugar chains to proteins. This sugar-adding process is called glycosylation. In ALG12-CDG, a gene named ALG12 does not work correctly. The ALG12 protein’s normal job is to put the eighth mannose sugar onto a growing sugar chain inside the cell. When ALG12 does not work, many proteins are made with incomplete sugars, so they cannot do their jobs well. Because many organs need these sugar-coated proteins, many body systems can be involved—brain, nerves, muscles, immune system, blood clotting, bones, heart, kidneys, eyes, and more. ALG12-CDG is autosomal recessive, which means a child gets one non-working copy of the ALG12 gene from each parent. cdghub.com+3MedlinePlus+3NCBI+3

Common features include developmental delay, low muscle tone, seizures, small head size, unusual facial appearance, low antibody (IgG) levels with frequent infections, and clotting factor problems. Some children have skeletal changes and, less often, heart muscle weakness. Signs usually begin in infancy. PMC+4MedlinePlus+4PubMed+4

Carbohydrate-deficient glycoprotein syndrome type Ig is a very rare, inherited metabolic disease. Today doctors usually call it ALG12-CDG. It happens when a gene named ALG12 does not work properly. This gene makes an enzyme that builds a sugar chain (called an N-glycan) that must be attached to many proteins in our cells. The ALG12 enzyme adds the eighth mannose sugar to this growing chain inside the endoplasmic reticulum (the cell’s protein factory). When ALG12 is not working, many proteins are “under-glycosylated,” meaning they are missing sugars. Missing sugars can change protein shape and function all over the body, so many organs can be affected—especially the brain, muscles, immune system, and growth. ALG12-CDG is autosomal recessive. That means a child gets one faulty copy of the gene from each carrier parent. Signs usually start in infancy. Typical problems include weak muscle tone (hypotonia), developmental delay, feeding problems, poor weight gain, small head size (microcephaly), distinctive facial features, low antibody levels (especially IgG, causing frequent infections), and sometimes bleeding problems from low clotting factors. Orpha.net+4cdghub.com+4PubMed+4

Historical note: The first patients with ALG12-CDG were described in 2002. Before that, these conditions were grouped under “carbohydrate-deficient glycoprotein syndromes (CDGS).” PubMed+1

Other names

Doctors and families may see several names that mean the same condition:

  • ALG12-CDG (preferred modern name)

  • Congenital disorder of glycosylation type Ig (CDG-Ig)

  • Carbohydrate-deficient glycoprotein syndrome type Ig (CDGS-Ig) (older term)

  • Alpha-1,6-mannosyltransferase congenital disorder of glycosylation

  • ALG12 mannosyltransferase deficiency cdghub.com+2MedlinePlus+2

Types

There are no official “sub-types” within ALG12-CDG. Instead, ALG12-CDG is one member of the large CDG Type I group (problems in building or transferring the sugar chain). In classifications, Type Ig specifically equals ALG12-CDG. People with ALG12-CDG can have a spectrum of severity—from moderate developmental issues to severe multi-organ disease. Some studies also note a “dual” biochemical behavior (features of both Type I and II patterns on detailed glycan testing), but clinically it is still referred to as a Type I (Ig) disorder. Wikipedia+1

Causes

  1. Biallelic pathogenic variants in ALG12 (one from each parent) are the root cause. These variants can be missense, nonsense, frameshift, or splice-site changes that reduce or abolish enzyme activity. PubMed+1

  2. Loss of ALG12 enzyme function blocks addition of the eighth mannose to the lipid-linked oligosaccharide, stalling correct N-glycan assembly. Wikipedia

  3. Under-glycosylation of many proteins in the body leads to multi-system illness (brain, muscle, immune, clotting). JCI+1

  4. Autosomal recessive inheritance: having two faulty copies is required; carriers are usually healthy. MedlinePlus

  5. Consanguinity (parents related by blood) can increase the chance both parents carry the same rare variant. (General genetic principle for rare recessive diseases.) fcdgc.rarediseasesnetwork.org

  6. Enzyme misfolding from certain missense variants can make the protein unstable or quickly degraded. (Mechanism inferred in many CDG enzymes.) JCI

  7. Defective ER mannose transfer specifically impairs N-glycosylation steps inside the endoplasmic reticulum. Wikipedia

  8. Abnormal glycosylation of immunoglobulins (especially IgG) contributes to low IgG levels and infections. NCBI

  9. Abnormal glycosylation of coagulation factors contributes to bleeding or easy bruising. Orpha.net

  10. Disrupted brain development due to many neural proteins being under-glycosylated, leading to microcephaly and developmental delay. fcdgc.rarediseasesnetwork.org

  11. Neuromuscular involvement from poor glycosylation of muscle-related proteins, causing hypotonia. fcdgc.rarediseasesnetwork.org

  12. Feeding/gastrointestinal dysfunction because gut and swallowing muscles and control pathways are affected. MedlinePlus

  13. Growth failure (“failure to thrive”) due to high energy demands, feeding challenges, and systemic disease burden. MedlinePlus

  14. Skeletal findings in some patients (e.g., skeletal dysplasia) likely reflect abnormal glycosylation in cartilage/bone proteins. fcdgc.rarediseasesnetwork.org

  15. Hearing loss may appear when inner-ear proteins are under-glycosylated. fcdgc.rarediseasesnetwork.org

  16. Eye problems (ocular abnormalities) can occur because vision-related proteins also need proper glycans. fcdgc.rarediseasesnetwork.org

  17. Cardiac involvement (structural or functional) is reported in some patients. fcdgc.rarediseasesnetwork.org

  18. Hydronephrosis/renal issues have been described in case reports, showing kidney involvement in certain families. NCBI

  19. Variant-specific effects: different mutations can cause different residual activity and different severities (“genotype–phenotype” variation). ScienceDirect

  20. Early-life vulnerability: because glycosylation is vital from the start of life, problems usually appear in infancy. MedlinePlus

(In short: the single fundamental cause is faulty ALG12; the other “causes” listed describe how this defect leads to system-wide problems and which contexts/variants raise risk or shape severity.)

Common symptoms and signs

  1. Developmental delay – slower progress in sitting, standing, walking, and speaking because the brain and muscles do not work at full strength. fcdgc.rarediseasesnetwork.org

  2. Hypotonia (low muscle tone) – “floppy” muscles and weak posture due to impaired muscle and nerve protein function. fcdgc.rarediseasesnetwork.org

  3. Progressive microcephaly – head size becomes small for age as growth of the brain is affected. fcdgc.rarediseasesnetwork.org

  4. Feeding difficulty – trouble sucking, swallowing, or coordinating feeding; may need special feeding plans. MedlinePlus

  5. Failure to thrive – poor weight gain or slow growth from feeding issues and high energy needs. MedlinePlus

  6. Recurrent respiratory infections – frequent colds, ear infections, or pneumonia because IgG is low and does not fight germs well. fcdgc.rarediseasesnetwork.org+1

  7. Facial dysmorphism – features like prominent forehead, large ears, thin upper lip, which help doctors suspect a CDG. Orpha.net

  8. Coagulation problems – easy bruising or bleeding due to reduced glycosylation and levels of clotting factors. Orpha.net

  9. Intellectual disability – learning difficulties of varying degree due to brain involvement. fcdgc.rarediseasesnetwork.org

  10. Seizures – may occur in some patients because abnormal glycosylation affects neuronal networks. PMC

  11. Male genital hypoplasia – under-development of male genitalia noted in some boys. fcdgc.rarediseasesnetwork.org

  12. Hearing loss (sensorineural) – trouble hearing because inner-ear structures are affected. fcdgc.rarediseasesnetwork.org

  13. Eye problems – such as strabismus or other ocular issues; eye checks are important. fcdgc.rarediseasesnetwork.org

  14. Cardiac abnormalities – structure or rhythm issues in some patients; screening is advised. fcdgc.rarediseasesnetwork.org

  15. Distinct immune profile (hypogammaglobulinemia) – especially low IgG measured on blood tests. NCBI

Diagnostic tests

A) Physical examination

  1. Growth and head-circumference charting – measures height, weight, and head size over time; failure to thrive and microcephaly point toward a congenital metabolic disorder like ALG12-CDG. MedlinePlus+1

  2. Neurologic and tone assessment – checking posture, tone, reflexes, and milestones; hypotonia and delay raise suspicion for CDG. fcdgc.rarediseasesnetwork.org

  3. Dysmorphology exam – looks for facial features (prominent forehead, large ears, thin upper lip) that often occur in ALG12-CDG. Orpha.net

  4. Signs of bleeding – bruises, nosebleeds, or prolonged bleeding that suggest a clotting factor issue. Orpha.net

  5. General systems review – heart sounds, chest exam (recurrent infections), abdomen (organ size), joints, and skin to capture multi-system disease. fcdgc.rarediseasesnetwork.org

B) Manual/bedside tests

  1. Feeding/swallowing assessment – bedside checks by speech-language or feeding therapists to assess safety and efficiency; problems are common. MedlinePlus

  2. Hearing screening (otoacoustic emissions/bedside audiology) – early detection of sensorineural hearing loss. fcdgc.rarediseasesnetwork.org

  3. Vision screening – eye alignment and tracking to flag ocular abnormalities. fcdgc.rarediseasesnetwork.org

C) Laboratory and pathological tests

  1. Serum transferrin isoelectric focusing (TIEF) or LC-MS transferrin glycoform analysis – the front-line biochemical screen for CDG. In Type I disorders (including ALG12-CDG), patterns show decreased fully glycosylated transferrin with increased under-glycosylated forms. JCI+1

  2. N-glycan profiling of serum and/or IgG by mass spectrometry – defines the exact glycan “fingerprint,” and ALG12-CDG shows characteristic under-mannosylated patterns; in some reports, features of both Type I and II can appear. NCBI

  3. Quantitative immunoglobulins – often low IgG (hypogammaglobulinemia). This explains frequent infections and guides therapy (e.g., IVIG consideration). NCBI

  4. Coagulation panel – PT/INR, aPTT, and specific clotting factor levels (e.g., antithrombin, protein C/S, FV, FVIII). Many CDG show decreased glycosylated factors. Orpha.net

  5. Comprehensive metabolic panel and liver tests – to check liver involvement (enzymes, proteins) which can occur in CDG. JCI

  6. Genetic testing of the ALG12 gene – targeted sequencing or exome/genome testing confirms the diagnosis by finding two pathogenic variants. ScienceDirect

  7. Carrier testing for parents and at-risk relatives – clarifies inheritance, reproductive risk, and counseling. (Standard practice in autosomal recessive CDG.) MedlinePlus

  8. Newborn or infant expanded panels (where available) – some centers add CDG screens or rapid exome if early signs are present. (General CDG practice trend.) JCI

D) Electrodiagnostic tests

  1. EEG – looks for seizure activity or abnormal background if spells or developmental regression occur. (Seizures reported in ALG12-CDG case literature.) PMC

  2. EMG/NCS (electromyography/nerve conduction studies) – used when weakness or pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।" data-rx-term="neuropathy" data-rx-definition="Neuropathy means nerve damage or irritation causing pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।">neuropathy is suspected; helps separate central vs peripheral contributions to hypotonia. (General neuromuscular evaluation in CDG.) JCI

E) Imaging tests

  1. Brain MRI – assesses microcephaly, delayed myelination, cerebellar or cerebral atrophy, or structural anomalies that support a congenital glycosylation disorder. (Imaging is standard in CDG neurological work-ups.) JCI

  2. System-focused imaging – echocardiogram for heart issues, renal ultrasound for kidney anomalies (e.g., hydronephrosis in some ALG12-CDG families), skeletal surveys if dysplasia suspected, and ophthalmic imaging as needed. fcdgc.rarediseasesnetwork.org+1

Non-Pharmacological Treatments (Therapies & Others)

  1. Care coordination with a metabolic/clinical genetics team; this sets a detailed plan across systems. NCBI

  2. Physiotherapy to improve tone, posture, balance, and motor skills; prevents contractures. NCBI

  3. Occupational therapy for daily activities (feeding, dressing), hand skills, and adaptive tools. NCBI

  4. Speech and feeding therapy for safe swallowing, communication, and language. NCBI

  5. Nutritional support (high-calorie plans; thickened feeds) to sustain growth and immunity. MedlinePlus

  6. Spine management (bracing, seating systems) to slow scoliosis/kyphosis progression. NCBI

  7. Hearing support (hearing aids; classroom acoustics) if loss is present. fcdgc.rarediseasesnetwork.org

  8. Vision therapy and glasses where helpful for tracking and reading. PMC

  9. Seizure safety planning (sleep hygiene, trigger avoidance, rescue plan). MedlinePlus

  10. Infection prevention routines (hand hygiene, prompt care plans). Frontiers

  11. Vaccination per specialist advice (may tailor schedule if IgG is very low). Frontiers

  12. Dental care to reduce infection risk and support feeding comfort. MedlinePlus

  13. Physical medicine equipment (standing frames, AFOs, walkers) to build strength safely. NCBI

  14. Educational supports/IEP to match learning needs and communication style. MedlinePlus

  15. Mental health support for stress, anxiety, and family coping. BioMed Central

  16. Social work support for home services, transport, benefits, and respite care. BioMed Central

  17. Thrombosis prevention around procedures (hydration, line care, mobilization). CDG UK

  18. Bone health plan (weight-bearing, safe sunlight, diet, and monitoring). PMC

  19. Cardiac lifestyle (salt moderation, activity as tolerated, illness precautions). PMC

  20. Palliative care when needed to improve comfort and quality of life across stages. BioMed Central

Drug Treatments

(Purpose, usual class, simple dosing guidance, mechanism, key cautions. Always individualize with a specialist. Doses below are typical references; not medical advice.)

  1. Immunoglobulin replacement (IVIG or SCIG) – for low IgG with infections. Class: pooled antibodies. Dose: IVIG often 400–600 mg/kg every 3–4 weeks; SCIG weekly per product. Purpose: raise IgG. Mechanism: provides ready-made antibodies. Side effects: pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।" data-rx-term="headache" data-rx-definition="Headache means pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।">headache, fever, infusion reactions, rare thrombosis—monitor. Frontiers

  2. Levetiracetam – seizure control. Class: antiseizure. Dose: commonly 20–60 mg/kg/day in divided doses. Mechanism: modulates synaptic release. Side effects: sleepiness, mood change. MedlinePlus

  3. Valproate – alternative antiseizure (avoid if liver disease). Class: antiseizure. Dose: 10–60 mg/kg/day titrated. Mechanism: increases GABA; broad-spectrum. Side effects: weight gain, tremor, liver/pancreas risk—specialist monitoring required. MedlinePlus

  4. Rescue benzodiazepine (diazepam/buccal midazolam) for prolonged seizures. Mechanism: enhances GABA. Side effects: drowsiness, breathing depression—follow emergency plan. MedlinePlus

  5. Empiric/targeted antibiotics during infections. Class: varies by source. Dose: per guideline. Purpose: treat bacterial infections promptly. Side effects: GI upset, allergy, resistance. Frontiers

  6. Prophylactic antibiotics (e.g., TMP-SMX low dose) in recurrent bacterial infections after immunology review. Mechanism: suppresses common organisms. Risks: allergy, cytopenias—specialist plan required. Frontiers

  7. ACE inhibitor for proteinuria or heart support (e.g., enalapril). Class: RAAS blocker. Dose: often 0.1–0.5 mg/kg/day, titrate. Purpose: reduce protein leak, support heart. Mechanism: vasodilation and reduced intraglomerular pressure. Side effects: cough, high potassium, kidney effects—monitor. PMC

  8. Beta-blocker for cardiomyopathy (e.g., carvedilol). Class: beta-blocker. Dose: pediatric start low, titrate by cardiology. Purpose: improve heart function and symptoms. Mechanism: lowers adrenergic stress. Side effects: low heart rate, fatigue, low BP. cardiologyres.org

  9. Diuretics (furosemide) for edema or heart failure symptoms. Mechanism: increases urine to reduce fluid. Risks: electrolyte loss—monitor. PMC

  10. Corticosteroids (for nephrotic-type presentations if present and indicated). Mechanism: reduces kidney inflammation/leak. Risks: weight gain, mood changes, infection risk. (Use only if clearly indicated by nephrology.) PMC

  11. Anticoagulation/antiplatelet therapy (specialist-guided only) if thrombosis occurs or risk is high. Agents: LMWH, warfarin, or aspirin depending on situation. Risks: bleeding—hematology must supervise. RPTH Journal

  12. Vitamin D (drug-grade) for bone health if low. Mechanism: improves calcium handling. Risks: excess calcium if overdosed—monitor labs. PMC

  13. Bisphosphonates in severe pediatric osteoporosis (specialist decision). Mechanism: reduces bone resorption. Risks: fever post-infusion, bone pain. PMC

  14. Proton-pump inhibitor if severe reflux affects feeding or meds. Mechanism: lowers stomach acid. Risks: diarrhea, low magnesium with long use. MedlinePlus

  15. Antispasmodics for spasticity (e.g., baclofen). Mechanism: GABA-B agonist reduces muscle tone. Risks: sedation, weakness. MedlinePlus

  16. Acetazolamide (only if a neurologist finds PMM2-like cerebellar syndrome—not standard for ALG12). Note: helpful reports are for other CDG, not proven for ALG12. Frontiers

  17. Vaccines (drug biologics) per immunology plan; sometimes extra doses or timing changes when IgG is low. Risks: usual vaccine reactions; live vaccines need specialist review. Frontiers

  18. Iron therapy if iron-deficiency anemia is present. Mechanism: supports red-cell production. Risks: constipation, dark stools. MedlinePlus

  19. Pain medicines (acetaminophen/ibuprofen if safe) for musculoskeletal pain; avoid NSAIDs if kidney issues. Risks: stomach/kidney effects for NSAIDs. MedlinePlus

  20. Anti-reflux prokinetics (specialist-guided) to improve feeding tolerance when needed. Risks: drug-specific; monitor. MedlinePlus

Important context: Nutritional sugars that help other CDG types (e.g., mannose for MPI-CDG, galactose for PGM1-CDG) do not have evidence for ALG12-CDG at this time; care remains supportive. PMC+1

Dietary “Molecular” Supplements (supportive; discuss with your team)

  1. High-calorie formula or modular calories to reach growth targets and support immunity. MedlinePlus

  2. Protein optimization to maintain muscle and healing (renal status considered). MedlinePlus

  3. Vitamin D3 and calcium for bone health if low. PMC

  4. Omega-3 fatty acids for general anti-inflammatory support (food-first when possible).

  5. Riboflavin (B2) and thiamine (B1) – common mitochondrial-support vitamins sometimes used in neuro-metabolic care (evidence in ALG12 is limited). PMC

  6. Carnitine if low, to support energy use (check levels first). PMC

  7. Coenzyme Q10 for cellular energy (anecdotal in CDG; monitor response). PMC

  8. Magnesium if low (helps muscle and nerve function).

  9. Zinc if deficient (supports immunity and growth).

  10. Fiber and hydration to ease constipation and improve feeding tolerance.

(These are supportive; none “cure” ALG12-CDG.) PMC

Immunity booster / Regenerative / Stem-cell” Drugs

  1. IVIG/SCIG – the only well-accepted immune replacement when IgG is low and infections are frequent. See dosing above. Frontiers

  2. Targeted monoclonal prophylaxis (e.g., RSV prevention in infants at risk) may be considered on a case-by-case basis by specialists.

  3. Growth factors (e.g., G-CSF) – only if a child truly has neutropenia; not routine in ALG12-CDG. Hematologist must decide.

  4. Erythropoietin – for significant anemia if indicated; not disease-modifying.

  5. Hematopoietic stem-cell transplant (HSCT) – not standard for ALG12-CDG; may be discussed only in research or exceptional immune-defect settings; risks are high. PMC

  6. Gene therapy – research stage across CDG; none approved for ALG12-CDG yet. PMC

Surgeries/Procedures

  1. Gastrostomy tube – for severe feeding failure or unsafe swallowing; improves nutrition and lowers aspiration risk. MedlinePlus

  2. Spinal surgery – for progressive scoliosis/kyphosis when bracing fails; improves sitting, breathing mechanics, and care. NCBI

  3. Orchiopexy – for undescended testes in boys to protect fertility and lower torsion risk. MedlinePlus

  4. Cochlear implant – in severe sensorineural hearing loss to improve sound access. fcdgc.rarediseasesnetwork.org

  5. Cardiac procedures (e.g., device therapy; rarely transplant) – for advanced cardiomyopathy in expert centers. PMC

Prevention Tips

  1. Prompt infection care; low threshold to see a clinician. Frontiers

  2. Vaccination plan with immunology input if IgG is low. Frontiers

  3. Nutrition and hydration to support growth and immunity. MedlinePlus

  4. Spine monitoring (scheduled checks) to catch curves early. NCBI

  5. Clot prevention around lines/surgeries (line care, mobilization, hydration). CDG UK

  6. Bone health (weight-bearing activity and vitamin D as needed). PMC

  7. Seizure plan (rescue meds, fever control, sleep routine). MedlinePlus

  8. Cardiac follow-up if any heart signs. PMC

  9. Dental and oral care to reduce infection sources. MedlinePlus

  10. Genetic counseling for family planning and carrier testing. cdghub.com

When to See a Doctor (red flags)

  • Any fever, cough, ear pain, or chest signs in a child with low IgG. MedlinePlus

  • New seizures, prolonged seizures, or behavior change. MedlinePlus

  • Sudden swelling, severe headache, unusual bruising, or limb pain (possible clot/bleed). RPTH Journal

  • Breathing trouble, poor feeding, vomiting, or dehydration. MedlinePlus

  • Back curve that is getting worse, new weakness, or loss of skills. NCBI

  • Any heart symptoms (fast breathing at rest, sweating with feeds, fainting). PMC

What to Eat & What to Avoid

What to eat:

  • Regular balanced meals with enough calories and protein to support growth.

  • Iron-rich foods (meat, beans, leafy greens) if iron is low.

  • Dairy or fortified alternatives for calcium and vitamin D (or supplements if prescribed).

  • Fruits, vegetables, and fiber to help constipation.

  • Adequate fluids to prevent dehydration and support circulation. MedlinePlus+1

What to avoid or limit:

  • Long fasting (worsens low energy).

  • Excess salt if heart failure or edema is present. PMC

  • Unnecessary NSAIDs if kidney or clotting problems exist (ask your team). RPTH Journal

  • Unproven supplements that claim to “cure” CDG; discuss all products with your team first. PMC

FAQs

  1. Is ALG12-CDG the same as CDG-Ig?
    Yes—CDG-Ig is the older name; today it is ALG12-CDG. cdghub.com

  2. How common is it?
    Very rare. Exact numbers are unknown because many cases are missed.

  3. How is it inherited?
    Autosomal recessive—parents are usually healthy carriers; each pregnancy has a 25% chance to be affected. cdghub.com

  4. What is the main problem in the body?
    A broken step in N-linked glycosylation—the ALG12 enzyme cannot add the eighth mannose. NCBI

  5. Why are infections common?
    Because IgG antibodies can be low. Some children need immunoglobulin replacement. MedlinePlus+1

  6. What does the “type I transferrin pattern” mean?
    It is a blood test hint that points to a CDG problem early in the sugar-building pathway. Frontiers

  7. Is there a cure?
    No single cure yet. Care is supportive and preventive. Research is ongoing. cdghub.com

  8. Do special sugars help?
    Treatments like mannose or galactose help other CDGs (MPI-CDG, PGM1-CDG), not ALG12-CDG at present. PMC+1

  9. Can my child go to school?
    Yes, with supports (IEP, therapies, hearing/vision aids). Many children learn and progress.

  10. What about sports?
    Light to moderate activity is encouraged, based on tone, balance, heart, and spine status.

  11. Is surgery ever needed?
    Sometimes—for feeding tubes, spine correction, orchiopexy, cochlear implants, or advanced heart care. NCBI+2MedlinePlus+2

  12. How are clotting problems handled?
    With careful hematology input, blood tests, and sometimes anticoagulation if clots occur. RPTH Journal

  13. What does brain MRI show?
    Often cerebellar hypoplasia or related changes. PMC

  14. What is the outlook?
    It varies widely. Some children are severely affected, while others have mild features and live into adulthood. fcdgc.rarediseasesnetwork.org

  15. Should our family get genetic counseling?
    Yes, for carrier testing and future pregnancy options. cdghub.com

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 12, 2025.

 

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Medicine doctor / pediatrician for children / qualified clinician
Tests to discuss with doctor
  • Temperature chart and hydration assessment
  • CBC with platelet count if fever persists or dengue/other infection is possible
  • Urine test, malaria/dengue tests, chest evaluation, or blood culture only when clinically indicated
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?
  • Do I need antibiotics, or is this more likely viral?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Carbohydrate Deficient Glycoprotein Syndrome Type Ig

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area from the RX Article Professional Blocks panel.

More from this topic
  1. Congenital Epstein–Barr Virus Infection

    DefinitionCongenital? Epstein–Barr virus infection? means a baby is thought to get Epstein–Barr virus, or EBV, before birth while still inside the mother’s womb. EBV is also...

    April 4, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  2. Mother-to-Child Transmission of Enterovirus Infection

    DefinitionMother-to-child transmission of enterovirus infection? means an enterovirus infection? passes from a pregnant mother to her baby before birth, during labor, at the time of delivery,...

    April 4, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  3. Congenital Enterovirus Infectious Disease

    DefinitionCongenital? enterovirus infectious disease means an enterovirus infection? that is already present in the baby before birth or becomes apparent at birth or in the first...

    April 4, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  4. Congenital Enterovirus Infection

    DefinitionCongenital? enterovirus infection? means a baby is infected with an enterovirus before birth or around the time of birth from the mother. In very simple words,...

    April 3, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  5. Congenital Enterocyte Heparan Sulfate Deficiency

    DefinitionCongenital? enterocyte heparan sulfate deficiency is a real but ultra-rare genetic intestinal disease. It causes the small-intestine lining cells, called enterocytes, to lack heparan sulfate on...

    April 3, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  6. Congenital Dyserythropoietic Anemia Type 4

    DefinitionCongenital? dyserythropoietic anemia? type 4, often called CDA type IV, is a very rare inherited red blood cell disorder linked to KLF1 dysfunction. In this disease,...

    April 1, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  7. Congenital Dyserythropoietic Anemia

    DefinitionCongenital? dyserythropoietic anemia?, or CDA, is a rare inherited blood disease. In this disease, the bone marrow makes red blood cells in an abnormal way. Many...

    April 1, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  8. Congenital Dyshaematopoietic Anemia

    DefinitionCongenital? dyshaematopoietic anemia? is more commonly called congenital? dyserythropoietic anemia?, or CDA. It is a rare inherited blood disorder. In this disease, the bone marrow makes...

    April 1, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  9. Congenital Dyserythropoietic Anemia

    DefinitionCongenital? dyserythropoietic anemia?, often called CDA, is a rare inherited blood disorder. In this disease, the bone marrow makes red blood cells in an abnormal way....

    April 1, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  10. Carbohydrate-Deficient Glycoprotein Syndrome Type IE

    DefinitionCarbohydrate-deficient glycoprotein syndrome type Ie is an old name for DPM1-congenital? disorder of glycosylation, often written as DPM1-CDG. It is a very rare inherited metabolic disease....

    April 1, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)